Fundraising FoxPeregrine Ventures — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Chaim Lotan(Executive Officer, Director)Ronit Haviv(Executive Officer)David Lifschitz(Director)Ilan Shalom(Executive Officer)Leon Eting(Executive Officer)Itai Katsir(Executive Officer)
Co-investorsIncentive, Peregrine Ventures IncubatorPix Vine CapitalPeregrine
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investors20/20 HealthCare Partners LLCBosch VenturesNew Era Capital PartnersOrbiMedPitangoQuark Venture Inc.+2 more
BRAIN.Q Technologies develops brain-focused medical technology, applying AI and data science to advance treatments for stroke and other acute brain injuries.
AI & Machine LearningDigital HealthMedical Devices
Yotam Drechsler(Chief Executive Officer & Co-founder, Director)inEsther Shohami(Chief Scientific Officer & Co-founder)inAmir Salhuv(Chief Technology Officer)in
Co-investorsHanaco Venture CapitalIT-Farm CorporationMillhouseOurCrowd
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.